CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-10-30 | OCONNELL HOWARD V Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2014-10-30 | LUCAS ROGER C Director | Grant or award | +1,000 | 3,456 | ||
| 2014-10-30 | LUCAS ROGER C Director | Grant or award · Stock Optoin (right to buy) | +4,000 | 4,000 | ||
| 2014-10-30 | BAUMGARTNER ROBERT V Director | Grant or award | +1,000 | 5,000 | ||
| 2014-10-30 | BAUMGARTNER ROBERT V Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2014-09-09 | Dinarello Charles A Director | Exercise or conversion | +5,000 | $54.91 | $275K | 6,000 |
| 2014-09-09 | Dinarello Charles A Director | Exercise or conversion · Stock Options | −5,000 | 1,500 | ||
| 2014-08-14 | HOLBROOK KAREN A Director | Exercise or conversion | +5,000 | $57.06 | $285K | 6,000 |
| 2014-08-14 | HOLBROOK KAREN A Director | Sale | −5,000 | $95.54 | $478K | 1,000 |
| 2014-08-14 | HOLBROOK KAREN A Director | Exercise or conversion · Stock Option | −5,000 | 0 | ||
| 2014-08-12 | VERONNEAU MARCEL SVP - Clinical Controls | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-08-12 | REAGAN KEVIN J Senior VP - Biotech | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-08-12 | Kummeth Charles R. Chief Executive Officer | Grant or award | +11,129 | 43,984 | ||
| 2014-08-12 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +80,460 | 80,460 | ||
| 2014-08-12 | Hippel James Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2014-08-12 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-08-12 | EANSOR N DAVID SVP - Novus Biologicals | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-08-12 | Bazan J. Fernando Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-08-04 | Furlow Brenda S. SVP - General Counsel | Grant or award | +2,500 | 2,500 | ||
| 2014-07-02 | EANSOR N DAVID SVP - Novus Biologicals | Grant or award · Restricted Stock Units | +5,000 | 5,000 |
Page 69 of 75 · 1,487 trades